V8 Peptides — Engineered Performance
Research Library
Cagrilintide Stability: Factors and Shelf-Life Studies
CagrilintideReconstitution & Handling

Cagrilintide Stability: Factors and Shelf-Life Studies

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What determines how long cagrilintide stays stable in the lab? No validated shelf life has been published for research-grade material, so the laboratory must set one. The lyophilized powder is the stable state and is kept at 2–8 °C, or −20 °C for long-term holding, protected from heat, moisture and light. In solution, limiting factors are deamidation and hydrolysis, ring opening by reducing agents, aggregation, adsorption to plastic and freeze–thaw stress. A short stability study with a time-zero HPLC baseline and a stability-indicating method measures it. For laboratory research use only.

Questions about shelf life for a research peptide usually get a single number in reply. For cagrilintide no validated shelf life has been published for research-grade material, which is a more useful fact than it sounds: it means the laboratory is the party that decides how long a stock is trustworthy, and it needs a method for doing so. This article sets out the factors that limit stability, the degradation pathways relevant to a lipidated amylin analog, and a small, practical stability study any laboratory can run. It is separate from the step-by-step handling guide, cagrilintide reconstitution and storage, and concentrates on why stability fails and how to measure it. Cagrilintide is supplied for laboratory research use only; not for human consumption.

Two states, two sets of risks

A peptide exists in the lab in two states with very different stability profiles.

StateMain risksTypical control
---------
Lyophilized powderMoisture uptake, heat, light, slow chemical change in the solidCold storage, sealed glass, desiccated warm-up, protection from light
SolutionHydrolysis, deamidation, oxidation, aggregation, adsorption, microbial growthCold, short time in solution, aliquots, sterile technique

The cagrilintide product page gives the storage line that governs the first state: refrigerate at 2–8 °C, use −20 °C for long-term holding, and protect from heat, moisture and light. Solid peptides are far more stable than solutions because water is both a reactant and the medium for molecular motion, which is the reason peptide products are freeze-dried (the principles are described by Manning and colleagues, 2010, and by Wang, 1999). What is lyophilization covers the process.

Chemical degradation pathways

Deamidation and isomerization

Asparagine and, to a lesser extent, glutamine residues can lose their side-chain amide through a cyclic succinimide intermediate, and aspartic acid can isomerize to iso-aspartate by the same route. Geiger and Clarke described these reactions in peptides in 1987, and they are among the most common causes of slow change in a peptide in solution. The rate depends on pH, temperature and the neighboring residue; sequences with asparagine followed by glycine or serine are especially prone. Because amylin-family sequences are rich in asparagine, the pathway is relevant, though the actual rates for a given analog must be measured.

Oxidation

Methionine, cysteine and tryptophan are oxidation targets. The cysteines in cagrilintide are already paired in a disulfide ring, which protects them from oxidation but adds another risk: exposure to reducing agents or to thiol-disulfide exchange can open the ring. Hawe and colleagues' review of forced degradation of protein pharmaceuticals covers oxidation conditions and the analytical signatures that result.

Hydrolysis

Peptide bonds, especially those adjacent to aspartic acid, can be cleaved in acidic solution over time. The result is shorter fragments that are visible as new peaks by HPLC and as lower masses by mass spectrometry.

Physical degradation pathways

Aggregation

Amylin is among the best-known aggregation-prone peptides, and the engineered substitutions in the analog reduce that tendency without removing it (Westermark and colleagues review the fibrillization biology). Aggregation is favored by high concentration, agitation, air–water interfaces and some temperatures. Its effect on an experiment is a falling concentration of active monomer, which can be silent because the solution may remain clear.

Adsorption

The lipid side chain makes the molecule an amphiphile that sticks to hydrophobic surfaces. Goebel-Stengel and colleagues documented how plasticware and glassware choices affect recovery in peptide work, and the loss is proportionally greater in dilute solutions. For a dilute working standard the apparent instability may be only adsorption.

Freeze–thaw

Freezing concentrates solutes in the unfrozen fraction and creates ice–liquid interfaces, both of which can promote aggregation. Bhatnagar and colleagues separated these stresses and described how they affect proteins during freezing. The practical result is the rule to divide a stock into single-use portions and thaw each once.

Factors summarized

FactorEffectPractical control
---------
TemperatureRaises the rate of every degradation pathwayKeep cold; limit time at room temperature
pHAlters deamidation, hydrolysis and aggregation ratesUse a diluent of known pH; record it
ConcentrationHigher concentration favors aggregationPrepare the stock only as concentrated as needed
AgitationIntroduces air interfaces and foamSwirl; never shake
SurfacesAdsorption lossesLow-binding tubes and tips
LightCan drive oxidationKeep in the box or in foil
Freeze–thawAggregationSingle-use aliquots
MicrobesContamination and enzymatic breakdownSterile technique; bacteriostatic diluent for multi-entry stocks

Designing a small stability study

A laboratory that relies on a stock for weeks should measure its stability rather than infer it. A basic design has four parts.

1. Establish a baseline

On the day the stock is prepared, run an HPLC analysis and record the main-peak area, the retention time and the area of every other peak. If mass spectrometry is available, record the mass of the main species. This is time zero.

2. Choose conditions

Store portions under the conditions the work will actually use: for example at 2–8 °C, at −20 °C as a single-use frozen portion, and at room temperature as a stress condition. Keep the portions in the same container type that will be used in practice, since adsorption depends on it.

3. Sample on a schedule

Remove one portion per condition at planned intervals and analyze it exactly as at time zero. A schedule that doubles the interval each time covers a long period with few samples.

4. Judge with a stability-indicating method

A method is stability-indicating when it can resolve the intact molecule from its degradation products. Forced degradation, in which small portions are deliberately stressed with heat, acid, base or oxidant until about ten to twenty percent degrades, produces the degradants and shows whether the method separates them (Hawe and colleagues). If the stressed sample shows new peaks that the method resolves, the method can be trusted to detect change in the real samples. Understanding HPLC purity describes what the chromatogram does and does not show, and HPLC versus mass spectrometry explains why adding mass data is valuable.

An example schedule, described in outline

A laboratory planning a series of assays over about two months might set time points at day 0, 3, 7, 14, 28 and 56 for each storage condition. At each point it would analyze one untouched portion, record the intact-peak area as a percentage of the time-zero area, and note any new peak with its retention time. The aliquots are thawed once and discarded, so the thaw history of every sample is identical. After the series, a plot of intact fraction against time for each condition shows which storage tier is adequate for the duration of the work, and the point at which the intact fraction crosses the pre-set acceptance criterion defines the in-house use-by date. That date applies to that lot, that diluent, that container and that method. It is not a general shelf life for the compound, and the log should say so.

Reading results

The question to ask is how much of the intact peak remains and whether new peaks have appeared. The thresholds depend on the experiment: an assay tolerant of a few percent loss can use a stock for longer than one that needs tight concentration. Decide the acceptance criterion before measuring, record it, and apply it consistently. A decline in the main peak with no new peak points toward adsorption or aggregation to insoluble material, while new peaks point toward chemical change.

Record keeping

Each stock should carry a label with compound, lot, concentration, diluent, date, preparer and storage location. The log should record every thaw. When a result looks odd months later, those records separate a handling problem from a reagent problem. The reconstitution calculator can be used to fix the concentration arithmetic at preparation, and how long do reconstituted peptides last and peptide vial appearance: what is normal cover general guidance and visual checks. For the compound's broader background see the cagrilintide research guide.

Frequently asked questions

Is there a published shelf life for research-grade cagrilintide?

No validated shelf life has been published for research-grade material in solution. General practice is to keep solutions cold, limit time in solution and verify by HPLC when concentration matters.

What is the most stable form of cagrilintide?

The lyophilized powder in a sealed container, held at 2–8 °C for near-term use or −20 °C for long-term holding and protected from heat, moisture and light, as stated on the product page.

What chemical changes can occur in solution?

Deamidation and isomerization of asparagine and aspartate residues, oxidation, peptide-bond hydrolysis and, if reducing agents are present, opening of the disulfide ring.

Can a clear solution still be degraded?

Yes. Soluble oligomers, deamidated forms and adsorption losses do not make a solution cloudy. Only analytical methods such as HPLC and mass spectrometry can show them.

Why does freezing sometimes make things worse?

Freezing concentrates the peptide in the unfrozen fraction and creates ice interfaces, both of which can promote aggregation. Single-use portions thawed once avoid repeated stress.

What is a stability-indicating HPLC method?

One that separates the intact molecule from its degradation products. It is demonstrated by forced degradation, where deliberately stressed samples show new peaks that the method resolves.

What is forced degradation?

Exposing small portions of a sample to heat, acid, base, oxidant or light until a modest fraction degrades, to produce the degradants and test whether the analytical method detects them.

Why does a dilute standard seem to lose potency quickly?

Adsorption to container walls takes a larger share of the peptide at low concentrations, and a lipidated molecule adsorbs strongly. Low-binding plastics and fresh dilution reduce the loss.

What records should accompany a stock solution?

Compound, lot, concentration, diluent, preparation date, preparer, storage location and every thaw, so later results can be traced to handling.

Related reading: Cagrilintide Structure, Lipidation and Synthesis, Cagrilintide Primer: Names, Form and Lab Uses.

Related reading: Cagrilintide Receptor Pharmacology: In-Vitro Assays.

References

  1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  2. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
  3. Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
  4. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PMID: 3805008
  5. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
  6. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  7. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91(3):795-826. doi:10.1152/physrev.00042.2009

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.